Oramed Pharmaceuticals
ORMP
#8902
Rank
NZ$0.22 B
Marketcap
NZ$5.74
Share price
1.20%
Change (1 day)
60.76%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): NZ$1.44

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$1.37. In 2024 the company made an earnings per share (EPS) of NZ-$0.81 a decrease over its 2023 EPS that were of NZ$0.24.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.44-276.17%
2024NZ-$0.81-442.86%
2023NZ$0.24-114.89%
2022NZ-$1.6020.51%
2021NZ-$1.3239.29%
2020NZ-$0.95-31.71%
2019NZ-$1.39-4.65%
2018NZ-$1.468.86%
2017NZ-$1.34-9.2%
2016NZ-$1.4829.85%
2015NZ-$1.148.06%
2014NZ-$1.055.08%
2013NZ-$1.003.51%
2012NZ-$0.97137.5%
2011NZ-$0.41-60%
2010NZ-$1.02-0%
2009NZ-$1.02-16.67%
2008NZ-$1.22-25%
2007NZ-$1.63700%
2006NZ-$0.20303.56%
2005NZ-$0.05046

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
NZ$5.96 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$3.50 154.96%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
NZ-$10.08-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ-$0.32-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
NZ-$0.51-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel